Literature DB >> 12737442

Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.

C Quattropani1, B Ausfeld, A Straumann, P Heer, F Seibold.   

Abstract

BACKGROUND: A widespread increase in the use of complementary alternative medicine (CAM) by patients with inflammatory bowel disease (IBD) has been recognized. The aim of our study was to evaluate both the extent and the determinants of CAM use by outpatients with IBD.
METHODS: Outpatients of the IBD centre at the University Hospital of Berne and patients of two gastroenterology private practices in Olten (Switzerland) completed a mailed self-administrated questionnaire regarding alternative medicine. The questionnaire addressed the following topics: demographic variables; disease-related data; the use of 16 types of complementary medicine; comparison between attitudes towards alternative versus conventional medicine and out-of pocket expenses.
RESULTS: Alternative medicine has been used by 47% of the patients. Diagnosis, duration and activity of disease, gender, age, previous surgery were not predictive for the use of CAM. The most commonly used CAM methods were: homeopathy, acupuncture and traditional Chinese medicine. Reasons cited for the use of CAM were: lack of satisfaction with and side effects of conventional therapy and the perceived safety of CAM. Sixty-one percent of patients noted that their IBD had improved with the use of CAM. By contrast, 16% noted a flare during CAM therapies. Forty-seven percent of patients paid more than Euro400 per year for CAM.
CONCLUSIONS: Complementary medicine use is common in patients with IBD. Frequently cited reasons for the use of complementary therapies were safety of CAM; dissatisfaction with conventional therapies, including their side effects; and that CAM can be used in addition to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737442     DOI: 10.1080/00365520310000591a

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

1.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?

Authors:  Stacy A Kahn; Rita Gorawara-Bhat; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

3.  Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.

Authors:  Anthony P Wong; Ann L Clark; Elizabeth A Garnett; Michael Acree; Stanley A Cohen; George D Ferry; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-01       Impact factor: 2.839

Review 4.  Helping patients make informed choices about probiotics: a need for research.

Authors:  Richard R Sharp; Jean-Paul Achkar; Margaret A Brinich; Ruth M Farrell
Journal:  Am J Gastroenterol       Date:  2009-04       Impact factor: 10.864

Review 5.  Probiotics in inflammatory bowel diseases and associated conditions.

Authors:  David R Mack
Journal:  Nutrients       Date:  2011-02-17       Impact factor: 5.717

6.  Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.

Authors:  Stefanie Joos; Thomas Rosemann; Joachim Szecsenyi; Eckhart G Hahn; Stefan N Willich; Benno Brinkhaus
Journal:  BMC Complement Altern Med       Date:  2006-05-22       Impact factor: 3.659

7.  Homeopathy satisfaction in Iran.

Authors:  Ahmad Mahmoudian; Gholamhosein Sadri
Journal:  Iran J Nurs Midwifery Res       Date:  2014-09

8.  Traditional Chinese medicine combination therapy for patients with steroid-dependent ulcerative colitis: study protocol for a randomized controlled trial.

Authors:  Kai Zheng; Hong Shen; Jia Jia; Yuelin Lu; Lei Zhu; Lu Zhang; Zhaofeng Shen
Journal:  Trials       Date:  2017-01-10       Impact factor: 2.279

9.  Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.

Authors:  Pauliina Nousiainen; Laura Merras-Salmio; Kristiina Aalto; Kaija-Leena Kolho
Journal:  BMC Complement Altern Med       Date:  2014-04-04       Impact factor: 3.659

10.  Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.

Authors:  Jong-Chan Jang; Kang Min Lee; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2016-05-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.